ACS Medicinal Chemistry Letters · 2019 · 30 citations · 9 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryMolecular PharmacologyAntifibrotic TherapyCollagen DepositionFibrosisCollagen BindingCollagen BiologyCollagen Degradation InhibitionCollagen Iv Network FormationCytotoxicity AssaysSmall Molecule Antifibrotic AgentsType I Collagen ProductionType Iv Collagen
Herein, we report the discovery of a potent and selective dual DDR1/2 inhibitor, 7e (VU6015929), displaying low cytotoxicity, good kinome selectivity, and possessing an acceptable in vitro DMPK profile with good rodent in vivo pharmacokinetics. VU6015929 potently blocks collagen-induced DDR1 activation and collagen-IV production, suggesting DDR1 inhibition as an exciting target for antifibrotic therapy.
9